Routine share-reward plan transactions with no discretionary signal. Ignore for trading purposes; no follow-up required.
Price Chart
Executive Summary
GSK filed a routine Form 6-K on June 11, 2026, disclosing eight PDMR transactions under the company's Share Reward Plan. Seven senior executives and one PCA acquired a total of 110 ordinary shares at £18.8393 per share on June 9, 2026. These are formulaic, pre-planned plan acquisitions — not discretionary open-market buys — with trivial aggregate value (~£2,070). The filing carries no material financial or strategic content.
Key Facts
- Filed June 11, 2026, reporting transactions from June 9, 2026.
- Eight PDMRs/PCA acquired shares: Lynn Baxter, Julie Brown (CFO), James Ford, David Redfern, Regis Simard, Philip Thomson, Deborah Waterhouse, Victoria Whyte, and Neil Falkingham (PCA of Lynn Baxter).
- Type: acquisition under GSK's Share Reward Plan (partnership + matching shares).
- Share price: £18.8393 per share; individual acquisitions range from 12 to 14 shares.
- Total shares acquired: 110 ordinary shares; total consideration approximately £2,072 in GBP.
- All transactions on the London Stock Exchange (XLON).
- No open-market discretionary purchases; no sales reported.
Financial Impact
Trivial — aggregate value approximately £2,072 (110 shares × £18.8393), immaterial for a ~£104B market cap company.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-005880 |
| Document: 0001654954-26-005880-index-headers.html | 0001654954-26-005880 |
| Document: 0001654954-26-005880-index.html | 0001654954-26-005880 |
| Document: 0001654954-26-005880.txt | 0001654954-26-005880 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $50.01 $50.22 | ▲ +0.42% | ▼ −0.40% | $47.03 (−5.96%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 14, 2026 18d ago | 6-K | $50.05 $51.08 | ▲ +2.06% | ▲ +1.95% | $47.03 (−6.03%) |
Sep 11, 2026 21d ago | 6-K | $48.13 $50.22 | ▲ +4.34% | ▲ +4.56% | $47.03 (−2.29%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 10, 2026 22d ago | 6-K | $48.12 $51.06 | ▲ +6.11% | ▲ +6.61% | $47.03 (−2.27%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Sep 1, 2026 4w ago | 6-K | $50.66 $48.63 | ▼ −4.01% | ▼ −4.09% | $47.03 (−7.17%) |
Aug 26, 2026 5w ago | 6-K | $51.43 $50.44 | ▼ −1.92% | ▼ −1.80% | $47.03 (−8.56%) |
Aug 24, 2026 5w ago | 6-K | $51.78 $50.25 | ▼ −2.95% | ▼ −3.42% | $47.03 (−9.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access